Skip to main content
EMVISION MEDICAL DEVICES LTD logo

EMVISION MEDICAL DEVICES LTD — Investor Relations & Filings

Ticker · EMV ISIN · AU0000028375 ASX Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2018-12-10 Annual Report
Country AU Australia
Listing ASX EMV

About EMVISION MEDICAL DEVICES LTD

https://emvision.com.au/

EMVision Medical Devices Ltd is a medical technology company focused on the development and commercialization of portable medical imaging devices. The company specializes in electromagnetic microwave imaging technology designed for the rapid diagnosis and monitoring of stroke and traumatic brain injury. Its primary product is a portable brain scanner intended for use at the point of care, including intensive care units, emergency departments, and ambulances. By utilizing non-ionizing radiation, the technology provides a safe, cost-effective, and mobile alternative to traditional neuroimaging modalities like CT and MRI. The device aims to facilitate earlier clinical intervention by enabling bedside assessment, potentially improving patient outcomes through faster detection of ischemic and hemorrhagic strokes.

Recent filings

Filing Released Lang Actions
Accounts for Year End 30 June 2018 27 pages 534.8KB
Annual Report Classification · 100% confidence The document is titled 'Annual Report – 30 June 2018' and contains detailed financial statements, directors' report, review of operations, principal activities, significant changes in the state of affairs, information on directors, meetings of directors, shares under option, indemnity and insurance information, and other comprehensive disclosures typical of a full annual report. The document covers the full financial year ending 30 June 2018 and includes substantive financial data and analysis. It is not a brief announcement or a certification letter, but a full report. Therefore, it fits the definition of an Annual Report (10-K). FY 2018
2018-12-10 English
Employee Securities Incentive Plan 26 pages 285.1KB
Regulatory Filings Classification · 95% confidence The document is titled 'Employee Securities Incentive Plan' for EMvision Medical Devices Limited. It contains detailed clauses about definitions, eligibility, grant of securities, vesting, exercise, forfeiture, rights attaching to plan shares, disposal restrictions, administration, and other plan rules. The content is a comprehensive legal and procedural document outlining the terms and conditions of an employee securities incentive plan, which is a type of equity compensation plan. It is not a financial report, earnings release, regulatory filing, or announcement. It is also not a proxy statement or remuneration report, but rather a plan document governing employee securities incentives. Therefore, the document best fits the category of a Regulatory Filing (RNS) as it is a formal regulatory document related to corporate governance and securities but does not fit into more specific categories like remuneration or governance information.
2018-12-10 English
Securities Trading Policy 9 pages 148.0KB
Governance Information Classification · 95% confidence The document is a detailed Trading Policy of EMvision Medical Devices Limited, outlining insider trading prohibitions, blackout periods, dealing restrictions, approval and notification requirements for directors and employees regarding company securities. It is a governance-related document focused on internal rules and compliance with insider trading laws and ASX listing rules. There is no financial data, earnings information, or report publication content. It is not an announcement or a report but a policy document related to corporate governance practices. Therefore, the most appropriate classification is Governance Information (CGR).
2018-12-10 English
Pre-Quotation Disclosure 2 pages 144.9KB
Capital/Financing Update Classification · 95% confidence The document is a disclosure related to the completion of a share offer, the issue of shares and options, and details about securities restrictions and capital structure. It references the closing of an offer pursuant to a prospectus and the admission of the company to the official list and quotation on the ASX. The content focuses on capital raising and share issuance details rather than financial results, management changes, or regulatory certifications. The document length is 3369 characters, which is relatively short and primarily an announcement of capital raising and share issuance details. Therefore, it fits best under Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes.
2018-12-10 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.